ResearcherHarvard UniversityNo recent work listed
Bryan C. Fuchs
Matched on ORCID iD 0000-0002-2149-3081; OpenAlex author ID A5068858118. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 31
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 5
- Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Last author DOI 10.1158/1078-0432.ccr-18-1359↗
- Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Last author DOI 10.1242/dmm.034793↗
- A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. Co-author DOI 10.1016/j.canlet.2017.08.028↗
- A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biomaterials.2016.03.044↗
- Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. First author DOI 10.1016/j.surg.2013.05.004↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenneth K. Tanabe · 4 shared papers, 2013–2020 · strength 0.24
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
- Cristina R. Ferrone · 3 shared papers, 2016–2020 · strength 0.20
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Paper A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.biomaterials.2016.03.044↗
- Michael D. Lanuti · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Peter D. Caravan · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Derek J. Erstad · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Nabeel M. Bardeesy · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Theodoros P. Michelakos · 2 shared papers, 2017–2020 · strength 0.13
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. DOI 10.1016/j.canlet.2017.08.028↗
- Vikram Deshpande · 2 shared papers, 2016–2020 · strength 0.13
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.biomaterials.2016.03.044↗
- Christian T. Farrar · 1 shared paper, 2020 · strength 0.08
- Veronica Clavijo Jordan · 1 shared paper, 2020 · strength 0.08
- Motaz Qadan · 1 shared paper, 2020 · strength 0.08
- Akhil Chawla · 1 shared paper, 2020 · strength 0.08
- Theodore Sunki Hong · 1 shared paper, 2017 · strength 0.05
- Juan Cong · 1 shared paper, 2017 · strength 0.05
- Lei Cai · 1 shared paper, 2017 · strength 0.05
- Nan Zhang · 1 shared paper, 2017 · strength 0.05
- Soldano Ferrone · 1 shared paper, 2017 · strength 0.05
- Xinhui Wang · 1 shared paper, 2017 · strength 0.05
- Yangyang Wang · 1 shared paper, 2017 · strength 0.05
- Cristina Rosa Ferrone · 1 shared paper, 2017 · strength 0.05
- Keith D. Lillemoe · 1 shared paper, 2017 · strength 0.05
- David Tsai Ting · 1 shared paper, 2016 · strength 0.05
- Laura Indolfi · 1 shared paper, 2016 · strength 0.05
- Elazer Reuven Edelman · 1 shared paper, 2016 · strength 0.05
- Daniel A. Haber · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.